Press release
Glioblastoma Multiforme (GBM) Treatment Market: Strong Growth From 2024 to 2029 Fueled by Adavaced Diagnostic Technique, Improved Understanding of Tumor Biology and Emergence of Immunotherapies
Glioblastoma Multiforme (GBM) Treatment Market Insights
What Is The Projected Market Size Of The Global Glioblastoma Multiforme (GBM) Treatment Market And Its Growth Rate?
• The GBM treatment market will grow from $2.48 billion in 2024 to $2.74 billion in 2025 at a CAGR of 10.2%.
• The market size is projected to reach $4.1 billion in 2029 at a CAGR of 10.6%.
• Growth drivers include the emergence of immunotherapies, advanced precision medicine, and a better understanding of genetic markers.
What Is Driving The Growth In The Glioblastoma Multiforme (GBM) Treatment Market?
The increasing prevalence of brain disorders such as GBM is propelling growth in the market. As the aging population, compromised immune systems, overdiagnosis, radiation, air pollution, and other factors contribute to increasing brain disorders, there is a growing need for treatments to improve wellbeing. In 2022, around 25,050 malignant tumors of the brain or spinal cord cancer cases were diagnosed in the US, according to a report by the American Cancer Society, therefore, driving the growth of the GBM treatment market.
Request A Free Sample Copy:https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
Who Are the Key Players Driving Glioblastoma Multiforme (GBM) Treatment Market Growth?
Major companies operating in the GBM treatment market include:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• AstraZeneca PLC
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Jazz Pharmaceuticals Inc.
What Are The Key Trends In The Glioblastoma Multiforme (GBM) Treatment Market?
Key trends include:
• Increasing exploration of combination therapies.
• Integration of artificial intelligence in diagnosis and treatment planning.
• Rise in adoption of immunotherapeutic approaches.
• Advancement in medical tools and equipment.
What Are The Segments Of The Global Glioblastoma Multiforme (GBM) Treatment Market?
The GBM treatment market is segmented by:
• Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy.
• Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes.
• Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
• End-Use: Hospitals, Clinics, Ambulatory Surgical Centers.
Which Region Leads The Glioblastoma Multiforme (GBM) Treatment Market?
In 2024, North America was the largest region for the GBM treatment market. However, Asia-Pacific is expected to witness the fastest growth during the forecast period due to the increasing incidence of GBM and advancements in treatment options in the region.
Pre-book the Report for Swift Delivery:https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-gbm-treatment-global-market-report
What Is Covered In The Glioblastoma Multiforme (GBM) Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Glioblastoma Multiforme (GBM) Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Glioblastoma Multiforme (GBM) Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Glioblastoma Multiforme (GBM) Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Glioblastoma Multiforme (GBM) Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioblastoma Multiforme (GBM) Treatment Market: Strong Growth From 2024 to 2029 Fueled by Adavaced Diagnostic Technique, Improved Understanding of Tumor Biology and Emergence of Immunotherapies here
News-ID: 3841356 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for GBM
Glioblastoma Multiforme (GBM) Treatment Market Report 2024: Trends and Projectio …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Glioblastoma Multiforme (GBM) Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.66 billion In…
Goodpasture Syndrome (Anti-GBM Disease) With Excellent CAGR 5.30%
Goodpasture Syndrome Treatment market analysis report is a professional and a detailed market study focusing on primary and secondary drivers, market share, leading segments, and geographical analysis. This market report is a comprehensive background analysis of the ABC industry, which includes an assessment of the parental market. The report also aids in prioritizing market goals and attain profitable business. This analysis gives an examination of various segments that are relied…
Anti-GBM Autoantibody Disease Market - Embracing Immune Harmony: Anti-GBM Autoan …
Newark, New Castle, USA - new report, titled Anti-GBM Autoantibody Disease Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-GBM Autoantibody Disease market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-GBM Autoantibody Disease market. The report offers an overview of…
Glioblastoma Multiforme Treatment (GBM) Market: Trends, Opportunities & Regional …
The global glioblastoma multiforme treatment market is anticipated to rise significantly owing to key players adopting competitive strategies such as merger and acquisitions for marketing. According to a report by Transparency Market Research, the key players in the global glioblastoma multiforme treatment are adopting strategies such as development of biological drugs that helps in reducing the side effects in the patients which are caused due to consuming chemotherapeutic agents and…
Understanding Impact of COVID-19 on Glioblastoma Multiforme (GBM) Market
Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS)…
2019 - 2025 Glioblastoma Multiforme Treatment Market | GBM Market
Global Glioblastoma Multiforme Treatment Market, Its Market Trends And Analysis
Glioblastoma multiforme is the high-grade glioma and potent malignant brain tumor that affects glial cells. Glioblastoma multiforme contains the complexly differentiated neoplastic astrocytes which are the subtype of central nervous system. Glioblastoma multiforme is different from the anaplastic astrocytoma due to the presence of hyperplastic blood vessels and necrotic tissue.
Request Sample Report:
https://precisionbusinessinsights.com/request-sample?product_id=16248
The global glioblastoma multiforme treatment market is…
